Symbol="EYPT"
AssetType="Common Stock"
Name="Eyepoint Pharmaceuticals Inc"
Description="EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and markets ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company is headquartered in Watertown, Massachusetts."
CIK="1314102"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="LABORATORY ANALYTICAL INSTRUMENTS"
Address="480 PLEASANT STREET, SUITE B300, WATERTOWN, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="297736000"
EBITDA="-80353000"
PERatio="None"
PEGRatio="None"
BookValue="2.285"
DividendPerShare="0"
DividendYield="0"
EPS="-3"
RevenuePerShareTTM="1.065"
ProfitMargin="-2.574"
OperatingMarginTTM="-2.066"
ReturnOnAssetsTTM="-0.258"
ReturnOnEquityTTM="-0.836"
RevenueTTM="39793000"
GrossProfitTTM="26948000"
DilutedEPSTTM="-3"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.173"
AnalystTargetPrice="31.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.154"
PriceToBookRatio="0.727"
EVToRevenue="0.112"
EVToEBITDA="0.162"
Beta="1.248"
num_52WeekHigh="11.44"
num_52WeekLow="2.19"
num_50DayMovingAverage="6.71"
num_200DayMovingAverage="4.889"
SharesOutstanding="34301900"
DividendDate="2020-12-09"
ExDividendDate="None"
symbol="EYPT"
open="8.62"
high="8.82"
low="7.91"
price="8.04"
volume="323978.00"
latest_trading_day="2023-07-07"
previous_close="8.61"
change="-0.57"
change_percent="-6.6202%"
aroon_positive_momentum_days="78"
aroon_negative_momentum_days="0"
trend_strength="Strong Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="78"
Volume_recent_avg="693421"
Change_recent_avg="0.02"
Delta_recent_avg="0.56"
Variance_recent_avg="0.28"
Change_ratio_recent_avg="-0.22"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="78"
Aroon_momentum_negative="22"
image_negative_thumbnail_id_1="137"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0039.jpeg"
image_negative_thumbnail_id_2="1139"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0172.jpeg"
image_neutral_thumbnail_id_1="545"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0054.jpeg"
image_neutral_thumbnail_id_2="582"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0017.jpeg"
image_positive_thumbnail_id_1="1012"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0174.jpeg"
image_positive_thumbnail_id_2="963"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0125.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
